Concomitant Infection of Intestinal Parasites and Helicobacter Pylori
NCT05360940 · Status: UNKNOWN · Type: OBSERVATIONAL · Enrollment: 200
Last updated 2022-07-19
Summary
Intestinal parasitic infections such as Giardia lamblia, Entamoeba histolyica and Enterobius Vermicularis are among the most common infections worldwide.So parasitic infections are considered one of the major health problems in the world especially in developing countries.
Helicobacter pylori is a gram-negative,helical-shaped,motile bacillus bacterium,which colonizes the gastric mucosa.
H.pylori bacterium secretes urease,a special enzyme that converts urea to ammonia.
Ammonia reduces the stomach's acidity .This risk factor allows pathogenic intestinal protozoa such as G.lamblia to take the opportunity to cross through the stomach's increased pH and cause disease.
Conditions
- Dyspepsia Abdominal Burning Pain Diarrhea Dysentery
Interventions
- DIAGNOSTIC_TEST
-
H.pylori stool antigen rapid test and stool parasitological examination
200 stool samples ( 100 positive and 100 negative for H.pylori) after performance of H.pylori stool rapid antigen test then parasitological stool examination will be done
Sponsors & Collaborators
-
Sohag University
lead OTHER
Eligibility
- Min Age
- 1 Year
- Sex
- ALL
- Healthy Volunteers
- Yes
Timeline & Regulatory
- Start
- 2022-09-30
- Primary Completion
- 2023-02-28
- Completion
- 2023-07-31
Countries
- Egypt
Study Locations
More Related Trials
-
Study to Assess Efficacy and Safety of PF-06947386 in Japanese Adult Patients With Complicated Intra-abdominal Infection
NCT04927312 ·Status: COMPLETED ·Phase: PHASE3
-
Isolation and Characterization of Blastocystis Hominis as Apotential Human Pathogen
NCT05814861 ·Status: UNKNOWN
-
Oral Antibiotic Treatment of Helicobacter Pylori Reduces Intestinal Colonization Rates With Oxalobacter Formigenes
NCT01300039 ·Status: COMPLETED
-
Phenotypic and Genotypic Characterization of Escherichia Coli
NCT06462261 ·Status: NOT_YET_RECRUITING
-
One Sequencing Find All for Helicobacter Pylori Infection
NCT03837990 ·Status: UNKNOWN
-
A Comparative Study of Ampicillin/Sulbactam Versus Moxifloxacin in the Treatment of Complicated Intra-abdominal Infections
NCT00952796 ·Status: COMPLETED ·Phase: PHASE4
-
Characterization of Enterococci
NCT04777240 ·Status: COMPLETED
-
Bacterial Ano-rectitis Sexually Transmitted in a Specialized Consultation Center
NCT03625713 ·Status: UNKNOWN
-
A Comparative Phase IV Study Evaluating Efficacy & Safety Of Magnex(Cefoperazone-Sulbactam) In Intraabdominal Infections
NCT00360607 ·Status: COMPLETED ·Phase: PHASE4
-
Study Evaluating the Etiology of Intra-Abdominal Infections
NCT00244088 ·Status: COMPLETED
-
Antibiotic Resistant Bacteria Among Patients With Severe Intraabdominal Infections
NCT00860587 ·Status: UNKNOWN
-
Impact Of Bacterial Resistance On Healthcare Costs For Hospitalized Patients With Complicated Intra-Abdominal Infections
NCT00929643 ·Status: COMPLETED
-
Helicobacter Pylori Prevalence in Southern Region of Romania
NCT05874960 ·Status: COMPLETED
-
Epidemiology of H. Pylori Transmission
NCT02740140 ·Status: COMPLETED
-
Does Helipyl Eradicate
NCT04618159 ·Status: COMPLETED ·Phase: PHASE4
-
Appendicoliths in Acute Complicated Appendicitis Patients With Abscess
NCT06469086 ·Status: NOT_YET_RECRUITING
-
Emergence of Bacterial Resistance to Antibiotics in the Digestive Microbiota of Patients Treated With Anticancer Drugs
NCT07093593 ·Status: NOT_YET_RECRUITING ·Phase: NA
-
Detection of Biofilm Among Uropathogenic Escherichia Coli Clinical Isolates in Suez Canal University Hospitals
NCT06252428 ·Status: COMPLETED
-
Feasibility Studies to Inform Novel Proposals to Avert Community-Based Antimicrobial Resistance Spread
NCT02666274 ·Status: UNKNOWN
-
Study of the Intestinal Microbiota
NCT07058961 ·Status: RECRUITING
-
Study of the Ecological and Evolutionary Dynamics of Escherichia Coli in the Digestive Commensal Flora
NCT05153824 ·Status: RECRUITING
-
Effects of H.Pylori Eradication on Microbiome
NCT03231332 ·Status: ENROLLING_BY_INVITATION ·Phase: PHASE4
-
Prospective Multicenter Doubleblind Randomized Study of NXL104/Ceftazidime + Metronidazole vs. Meropenem in Treatment of Complicated Intra-abdominal Infections
NCT00752219 ·Status: COMPLETED ·Phase: PHASE2
-
The Role of Cathepsin X in Infection With the Helicobacter Pylori
NCT01137942 ·Status: UNKNOWN
-
GSK2251052 in the Treatment of Complicated Intra-abdominal Infections
NCT01381562 ·Status: TERMINATED ·Phase: PHASE2